The anatomy and physiology of the eye strongly limit the bioavailability of locally administered drugs. The entrapment of therapeutics into nanocarriers represents an effective strategy for the topical treatment of several ocular disorders, as they may protect the embedded molecules, enabling drug residence on the ocular surface and/or its penetration into different ocular compartments. The present work shows the activity of hyaluronan-cholesterol nanogels (NHs) as ocular permeation enhancers. Thanks to their bioadhesive properties, NHs firmly interact with the superficial corneal epithelium, without penetrating the stroma, thus modifying the transcorneal penetration of loaded therapeutics. Ex vivo transcorneal permeation experiments show that the permeation of hydrophilic drugs (i.e., tobramycin and diclofenac sodium salt), loaded in NHs, is significantly enhanced when compared to the free drug solutions. On the other side, the permeation of hydrophobic drugs (i.e., dexamethasone and piroxicam) is strongly dependent on the water solubility of the entrapped molecules. The obtained results suggest that NHs formulations can improve the ocular bioavailability of the instilled drugs by increasing their preocular retention time (hydrophobic drugs) or facilitating their permeation (hydrophilic drugs), thus opening the route for the application of HA-based NHs in the treatment of both anterior and posterior eye segment diseases.

Hyaluronan-cholesterol nanogels for the enhancement of the ocular delivery of therapeutics / Zoratto, Nicole; Forcina, Laura; Matassa, Roberto; Mosca, Luciana; Familiari, Giuseppe; Musarò, Antonio; Mattei, Maurizio; Coviello, Tommasina; Di Meo, Chiara; Matricardi, Pietro. - In: PHARMACEUTICS. - ISSN 1999-4923. - 13:11(2021), pp. 1-19. [10.3390/pharmaceutics13111781]

Hyaluronan-cholesterol nanogels for the enhancement of the ocular delivery of therapeutics

Zoratto, Nicole
Primo
;
Forcina, Laura;Matassa, Roberto;Mosca, Luciana;Familiari, Giuseppe;Musarò, Antonio;Coviello, Tommasina;Di Meo, Chiara
Penultimo
;
Matricardi, Pietro
Ultimo
2021

Abstract

The anatomy and physiology of the eye strongly limit the bioavailability of locally administered drugs. The entrapment of therapeutics into nanocarriers represents an effective strategy for the topical treatment of several ocular disorders, as they may protect the embedded molecules, enabling drug residence on the ocular surface and/or its penetration into different ocular compartments. The present work shows the activity of hyaluronan-cholesterol nanogels (NHs) as ocular permeation enhancers. Thanks to their bioadhesive properties, NHs firmly interact with the superficial corneal epithelium, without penetrating the stroma, thus modifying the transcorneal penetration of loaded therapeutics. Ex vivo transcorneal permeation experiments show that the permeation of hydrophilic drugs (i.e., tobramycin and diclofenac sodium salt), loaded in NHs, is significantly enhanced when compared to the free drug solutions. On the other side, the permeation of hydrophobic drugs (i.e., dexamethasone and piroxicam) is strongly dependent on the water solubility of the entrapped molecules. The obtained results suggest that NHs formulations can improve the ocular bioavailability of the instilled drugs by increasing their preocular retention time (hydrophobic drugs) or facilitating their permeation (hydrophilic drugs), thus opening the route for the application of HA-based NHs in the treatment of both anterior and posterior eye segment diseases.
2021
hyaluronan; nanogels; ocular delivery; permeation enhancer
01 Pubblicazione su rivista::01a Articolo in rivista
Hyaluronan-cholesterol nanogels for the enhancement of the ocular delivery of therapeutics / Zoratto, Nicole; Forcina, Laura; Matassa, Roberto; Mosca, Luciana; Familiari, Giuseppe; Musarò, Antonio; Mattei, Maurizio; Coviello, Tommasina; Di Meo, Chiara; Matricardi, Pietro. - In: PHARMACEUTICS. - ISSN 1999-4923. - 13:11(2021), pp. 1-19. [10.3390/pharmaceutics13111781]
File allegati a questo prodotto
File Dimensione Formato  
Zoratto_Hyaluronan‐cholesterol_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 488.27 kB
Formato Adobe PDF
488.27 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1582930
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact